An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 04/22/2025 8:42 PM
Question 20200079
Inquiry Details
References:
Solid Tumor Rules. Non-malignant CNS Tumors; December 2020 Update
Question:
Solid Tumor Rules (2018)/Primary Site--Brain and CNS: Should the updated note for optic nerve glioma be included in both the 2018 Solid Tumor Rules for Malignant Central Nervous System (CNS) and Peripheral Nerves, Note 6, and the Non-Malignant CNS Tumors, Note 5? See Discussion.
Discussion:
Should the updated Note 5 from the Non-malignant CNS regarding optic nerve glioma also be incorporated into Note 6 for Malignant CNS rules (the pilocytic astrocytoma note)?
This was one of the major issues identified in the SEER*Educate Workshop. Registrars have demonstrated they do not consistently think to look at the Non-malignant CNS schema when they see the term glioma and continue to misclassify optic nerve gliomas as malignant.
This question was prompted from preparing SEER*Educate coding exercises. We will use the answer as a reference in the rationales.
Answer:
The 2022 Solid Tumor Update will include a new note in the Terms & Definitions, Introduction section that will state: See the Non-malignant CNS rules when the primary site is optic nerve and the diagnosis is either optic glioma or pilocytic astrocytoma. The behavior is non-malignant and coded 9421/1.
